Кращі подкасти про Drug Discovery News (2024)

1
Targeting inflammation: A revolution in disease treatment 43:10

3d ago43:10

43:10

Inflammation appears to affect almost every part of the human body as we age, including cancer, type-2 diabetes, obesity, and neurodegenerative disorders. NLRP3 inflammasome-induced inflammation is at the root of nearly all disease pathologies including fibrotic, dermatological, rheumatological diseases as well as neurological disorders such as Alz…

1
1047.mp3 13:21

7d ago13:21

13:21

1
The power of tumor infiltrating lymphocytes to fight melanoma 38:03

10d ago38:03

38:03

Tumor infiltrating lymphocyte (TIL) therapy uses a person’s own immune cells to fight advanced melanoma, offering new hope for patients who have limited treatment options. This week, we have a conversation with Brian Gastman, EVP of medical affairs at Iovance Biotherapeutics, about TILs and the company’s pipeline. Iovance recently submitted a marke…

1
How Mio Connects Google Workspace and Collaboration Tools Effortlessly | EP 187 21:33

13d ago21:33

21:33

Explore the challenges and innovations in cross-platform collaboration as Tom Hadfield, CEO of Mio, discusses how his company is bridging the communication gap between Google Workspace and other collaboration tools on SADA’s Cloud and Clear podcast. This episode delves into the importance of chat interoperability and how Mio is enabling enterprises…

1
The future of combination vaccines 24:44

17d ago24:44

24:44

The development of combination vaccines could represent a significant advancement in the fight against infectious diseases. With the potential to streamline the vaccination process and provide broader protection, these vaccines could greatly improve public health preparedness. Moderna is harnessing the power of its mRNA platform to develop vaccines…

1
New German biotech spins out to develop radiotherapeutics 18:35

24d ago18:35

18:35

Pentixapharm is a clinical-stage radiopharmaceutical development company targeting a range of diseases. While it is currently owned by the Eckert & Ziegler Group, it will soon be spun off as a separate company. Pentixapharm’s clinical pipeline includes PENTIXATHER, am Yttrium-90 based therapeutic against CNS lymphoma, and PENTIXAFOR, a Gallium-68 b…

1
Insight and SADA: Driving AI-Powered Multicloud Solutions | EP 186 21:24

27d ago21:24

21:24

In this episode of SADA’s Cloud and Clear podcast, join host Veronica Raulin, Sr. Director of Advisory at SADA, as she sits down with Jeff Bozic, Distinguished Technologist at Insight, to discuss the dynamic landscape of cloud security, AI, and how their strategic partnership is driving innovation in these fields. Jeff shares his experiences and in…

1
Challenging the European biotech funding status quo 36:36

1M ago36:36

36:36

There are many questions when it comes to setting up a biotech company, and raising funds. Currently, many companies are concerned about fundraising, but there are things that can be done to maximize efforts. Does a company’s location affect fundraising? What is the best approach to successfully raise funds? What are the current trends in biotech f…

1
Healing a broken heart 18:05

1M ago18:05

18:05

After a heart attack, the damage is permanent — for now. Researchers are testing innovative ways to get the heart to regenerate muscle cells and fix itself.Drug Discovery News

1
[Rebroadcast] Epigenetic editing – the power of CRISPR without cutting DNA 32:57

1M ago32:57

32:57

While our podcast takes a brief break, Labiotech invites you to enjoy some of our favorite episodes. We will return with a brand-new episode on August 16, 2024! Have an awesome summer! Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) inc…

1
Email Security Revolution: A Deep Dive with Material Security | EP 185 21:52

1M ago21:52

21:52

In this episode of Cloud and Clear, your host John Veltri sits down with Abhishek Agarwal, Co-Founder and CEO of Material Security. They dive into the intricacies of cloud security, focusing on Google Workspace, and discuss how Material Security addresses the evolving threats in this space. From email security to sensitive content management and th…

1
[Rebroadcast] How does AI assist drug discovery? 38:40

1M ago38:40

38:40

While our podcast takes a brief break, Labiotech invites you to enjoy some of our favorite episodes. We will return with a brand-new episode on August 16, 2024! Have an awesome summer! Artificial intelligence (AI) is certainly in the news constantly; however, it’s been used in drug discovery for some time. A new collaboration between artificial int…

1
The first mass-market cell therapy? 25:34

2M ago25:34

25:34

Aurion Biotech is a US biotech with a regenerative medicine platform, developing novel therapies to restore vision to millions of people in need. This week on the podcast, we have a conversation with CEO Greg Kunst about Aurion’s pipeline, and how the company’s treatment could be the first mass-market cell therapy available. The FDA has granted the…

1
Transforming Healthcare: Verily’s 50 Petabyte Data Migration Journey | EP 184 20:04

2M ago20:04

20:04

Join Miles Ward, CTO at SADA, as he delves into the world of massive data migration with Joe Intrakamhang, Head of Data Management and Cost Optimization at Verily. Discover how SADA and Google Cloud collaborated to move an astounding 50+ petabytes of data for Verily, a leader in precision healthcare. Learn about the challenges and triumphs of this …

1
Cutting through the AI hype in drug discovery 26:13

2M ago26:13

26:13

LabGenius is a drug discovery company developing next-generation therapeutic antibodies. The company’s discovery platform, EVA, integrates several technologies drawn from the fields of artificial intelligence (AI), robotic automation and synthetic biology. LabGenius operates under a hybrid business model that involves partnering with large biotech …

1
The Growing Epidemic of Elderly Abuse 12:35

2M ago12:35

12:35

The number of senior citizens is growing rapidly; individuals aged 65 and older increased from 39.6 million in 2009 to 54.1 million in 2019 (a 36% increase) and is projected to reach 94.7 million by 2060. However, over the last few years, the usual respect and care of our aging population is decaying into a growing incidence of neglect and abuse. P…

1
How biotechs are revolutionizing acute on-chronic liver failure? 29:22

2M ago29:22

29:22

Acute on-chronic liver failure (ACLF) is a significant healthcare issue with high unmet needs for patients and clinicians, and a massive burden for healthcare systems. It cost more than $6bn in the US alone in 2021, with a drastic increase over the last 10 years. Genfit is a late-stage biopharma company taking on rare, life-threatening liver diseas…

1
AI Revolution for Retail: Simplifying Pricing and Promotion | EP 183 22:55

2M ago22:55

22:55

Join us on Cloud and Clear, SADA's cloud transformation podcast. This episode features leaders from Revionics and Google Cloud discussing the transformative impact of AI in retail. Discover how AI enhances customer experience, optimizes pricing, and drives operational excellence. Learn about the role of Google Cloud in powering these advancements a…

1
The radiotherapeutics boom 39:43

2M ago39:43

39:43

The field of radiotherapeutics is a hot topic currently, and so who better to talk about the subject than Ken Herrmann, a radiopharmaceutical academic expert, who is Professor of Nuclear Medicine at the Universitätsklinikum Essen, in Essen Germany, and two people from the company Molecular Partners: Patrick Amstutz, who is a co-founder and the CEO,…

1
The antibiotics hidden in medieval recipes 25:38

3M ago25:38

25:38

Could the solution to antibiotic resistance already have been discovered? Microbiologists and historians probe medieval and ancient texts to find out.Drug Discovery News

1
Priovant - finding options to treat autoimmune diseases 30:05

3M ago30:05

30:05

US-based biotech company Priovant Therapeutics is dedicated to developing novel therapies for autoimmune diseases with high morbidity and few available treatment options. The company's lead asset, brepocitinib, is a dual selective inhibitor of TYK2 and JAK1. Through dual TYK2/JAK1 inhibition, brepocitinib suppresses key cytokines linked to autoimmu…

1
AI Trends and Innovations with SADA | EP 182 23:13

3M ago23:13

23:13

In this episode of Cloud and Clear, host Nikki Harley, VP of Ecosystem and Solutions at SADA, talks with Scott Bergquist, who leads SADA's go-to-market strategy for data, AI, and industry solutions. Scott, with over 25 years in tech, shares his insights on the rapid advancements and transformative potential of AI in business. They discuss how SADA …

1
How ADCs can deliver death cap mushroom toxins to treat cancer 28:09

3M ago28:09

28:09

Heidelberg Pharma is a clinical stage biotech company developing antibody drug conjugates (ADCs). Its lead amanitin-based ADC product candidate, HDP-101, targets relapsed or refractory multiple myeloma. HDP-101 recently received orphan drug designation; it is currently in a phase I/IIa clinical trial, demonstrating first signs of clinical efficacy.…

1
Looking to cure Type 1 diabetes 23:40

3M ago23:40

23:40

Diamyd Medical develops precision medicine therapies for the prevention and treatment of Type 1 diabetes and LADA (latent autoimmune diabetes in adults). Diamyd is an antigen-specific immunomodulatory therapeutic for the preservation of endogenous insulin production. It has been granted Orphan Drug Designation in the U.S. as well as Fast Track Desi…

1
Mastering Real-Time Customer Data Analysis with Quantum Metric and AI | EP 181 30:59

3M ago30:59

30:59

In this episode, Tony Safoian interviews Mario Ciabarra, the CEO and founder of Quantum Metric. They discuss Mario's background and journey as an entrepreneur, as well as the evolution of Quantum Metric and its product. They highlight the importance of understanding and listening to customers to improve digital experiences. They also introduce the …

1
Developing treatments for rare pediatric diseases 29:17

3M ago29:17

29:17

Rare diseases affect around 1 in 2,000 people. Many of the thousands of rare diseases are difficult to diagnose. Of the known rare diseases, about 80% have genetic causes. Leukodystrophies are a group of rare genetic disorders for which there is currently no curative therapy. This week on the podcast we are discussing novel treatments of rare pedia…

1
Can cell therapy tackle hearing loss? 31:00

4M ago31:00

31:00

Hearing loss is a huge – and growing – global challenge. Using its OSPREY platform, UK-based Rinri Therapeutics is developing a portfolio of off-the-shelf regenerative cell therapy products to address sensorineural hearing loss, a significant global medical challenge. The company’s lead asset, Rincell-1, is designed to regenerate auditory neurons a…

1
Rejuvenating the retina to save vision 15:07

4M ago15:07

15:07

In diabetic macular edema, senescent cells build up in the retina, leading to vision loss. A new drug forces these undead cells to die, healing the retina.Drug Discovery News

1
From De-Extinction to Drug Discovery: SADA Explores the Future of Life Sciences with Form Bio | EP 180 19:21

4M ago19:21

19:21

Cloud and Clear, SADA's Cloud Transformation podcast, brings in Michael Ames, Managing Director of Industry Professional Services at SADA, to highlight Form Bio. We introduce Chris Haas, Head of Partner Engineering, and Doug Daniels, Chief Technology Officer at Form Bio, to talk to us about some amazing things that they're doing in genetic engineer…

1
How biotech is tackling myasthenia gravis 28:50

4M ago28:50

28:50

June is myasthenia gravis awareness month. Myasthenia gravis is a chronic autoimmune disorder where antibodies destroy the communication between nerves and muscle, and this results in weakness of the skeletal muscles. It especially affects the voluntary muscles of the eyes, mouth, throat and/or limbs. It is most frequent in women from 20 and 30 and…

1
Antisense oligonucleotides 27:22

4M ago27:22

27:22

German-headquartered Isarna Therapeutics is developing a portfolio of antisense therapies targeting an emerging therapeutic field in human biology – transforming growth factor beta (TGF-B) signaling. Precise modulation of TGF-B pathways using antisense therapy may result in safer and more effective treatment options for a broad range of indications…

1
Delivering Security: Papa Johns’ Cloud-Based Pizza Revolution | EP 179 23:52

4M ago23:52

23:52

Join host Rocky Giglio in this engaging episode of "Cloud and Clear" as he sits down with Sarika Attal and Shellie Dreistadt from Papa Johns'. Dive into a discussion on leveraging cloud technology and security at scale in the fast-paced world of pizza delivery. Sarika, VP, EA, Tech Services & Store Platforms, shares insights into the tech-driven op…

1
Making waves in cardiovascular disease treatment 21:02

4M ago21:02

21:02

Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. This week, we have a conversation with the …

1
From warhead to cancer-killer, the quest for more actinium-225 28:52

4M ago28:52

28:52

Actinium-225 is a radioactive isotope that kills cancer cells with a burst of alpha particles, but it was difficult to make enough of it — until now. https://www.drugdiscoverynews.com/from-warhead-to-cancer-killer-the-quest-for-more-actinium-225-15934Drug Discovery News

1
New ways to treat Duchenne muscular dystrophy 23:56

5M ago23:56

23:56

Duchenne muscular dystrophy (DMD) is a genetic disorder with progressive muscle degeneration and weakness due to changes in the protein dystrophin, which helps keep muscle cells intact. There are few treatments for DMD, although recent advances mean that males – who are primarily affected by DMD – can now sometimes survive into their 30s. More drug…

1
Behind the Bouquet: FTD’S CLoud Transformation with SADA | EP 178 26:43

5M ago26:43

26:43

Join us for a special Mother’s Day edition of Cloud and Clear from SADA, featuring an in-depth discussion with Steve Ridley, VP of Infrastructure at FTD. Hosted by Michael Ames, Managing Director at SADA, this episode dives into FTD’s transformative journey from on-premises data centers to the dynamic world of cloud computing. Discover how FTD leve…

1
Overcoming clinical trial challenges 26:00

5M ago26:00

26:00

This week, we have a conversation about clinical trial design with Gen Li, the president and founder of Phesi, a global provider of patient-centric data analysis. Earlier this year, Phesi’s global analysis of all clinical trials conducted in 2023 revealed that more than a quarter (28%) of trials were cancelled during phase II – above the average at…

1
LAMA Model- Latest Release 3:02

5M ago3:02

3:02

Let's start by unpacking LLM-based approaches, also known as Large Language Models. These models, like LAMA 3, are at the forefront of natural language processing and understanding. LAMA 3, for instance, leverages the power of large-scale language models to tackle a wide range of tasks, from text generation to question answering, with unprecedented…

1
The biotech investment landscape in 2024 28:32

5M ago28:32

28:32

RTW is a global multi-strategy investment firm focused on supporting innovative biotech and biopharma companies across the US, Europe, and China. The company invests in both public and private companies across their entire life cycle, with a focus on those addressing next-generation gene and RNA therapies, rare diseases, targeted oncological, cardi…

1
From Startup to AI Pioneer: FullStory's Transformative Journey | EP 177 24:24

5M ago24:24

24:24

In this episode of the Cloud and Clear podcast, hosted by Tony Safoian, CEO of SADA, we delve into a captivating conversation with Scott Voigt, CEO and Co-founder of FullStory. Recorded at FullStory's headquarters near Buckhead in Atlanta, GA, this installment of the CEO series explores the fascinating origin and evolution of FullStory, a company a…

1
Redefining chronic pain treatment 35:42

5M ago35:42

35:42

Doloromics is a precision neuropharmaceuticals company. It was set up four years ago, to use newer technologies, particularly in the omics space, to take advantage of different single-cell transcriptomic technologies or proteomic technologies to better understand the progression of neurological diseases like chronic pain. The Doloromics pipeline is…

1
Colossal aims to bring back mammoth by 2028 38:24

5M ago38:24

38:24

Based in Austin, Texas, biotech Colossal Biosciences is at the forefront of de-extinction, critically endangered species protection and the repopulation of critical ecosystems. Its mission is to use CRISPR technology to bring back extinct animals, such as the mammoth, the thylacine, and the dodo. Since DNA was recovered in 2021 from mammoths frozen…

1
The SADA and Wiz Alliance: Building a Secure Future with AI | EP. 176 20:29

6M ago20:29

20:29

In this episode of Cloud and Clear, host Rocky Giglio, Global Director of Security at Sada, welcomes Scott Sumner, Director of Global Strategic Alliance at Wiz, for an in-depth conversation about the forefront of cloud security and artificial intelligence. They dive into Wiz's rapid development pace, highlighting its continuous release of features …

1
Sex differs in matters of the heart 19:57

6M ago19:57

19:57

An off-the-cuff request at the local butcher led to a serendipitous discovery about heart valve disease, leading to potential new sex-specific ways to treat it.Drug Discovery News

1
Guiding Signal for AI Career 3:15

6M ago3:15

3:15

Embark on a journey to master the art of machine learning with our podcast, "Unlocking the Path." Whether you're an aspiring data scientist or a seasoned professional looking to enhance your skills, this podcast is your guide to success in the world of artificial intelligence. Join us each week as we explore the essential prerequisites and foundati…

1
New treatments being developed for schizophrenia 25:31

6M ago25:31

25:31

It would appear that 2024 is shaping up to be a big year for the development of treatments for schizophrenia, with several clinical trials under way. Recently, Boehringer Ingelheim and Sosei Group Corporation (Sosei Heptares) announced a global collaboration and exclusive option-to-license agreement. This is to develop and commercialize Sosei Hepta…

1
Multi-Cloud Mastery: How Businesses Win with a Hybrid Approach Part 2 | EP 175 17:35

6M ago17:35

17:35

Join us for an enlightening discussion on the rapidly evolving tech landscape in 2024. Miles Ward and Juan Orlandini delve into the complexities of navigating cost efficiency, hybrid cloud, and multi-cloud strategies amidst rising prices and continuous changes. Discover how companies are adapting through development, infrastructure adjustments, and…

1
Reformulating psychedelics for neurodegenerative diseases 41:37

6M ago41:37

41:37

There is a clear demand for novel, neurological treatments. While it’s widely known psychedelics hold enormous therapeutic potential, there are a host of challenges, including dosing and potential side effects for the patient. Our guest this week is Dr Sam Clark, who founded Terran Biosciences to develop a safe, effective portfolio of therapeutics …

1
How AI immune system mapping can boost drug discovery 28:46

6M ago28:46

28:46

Immunai is mapping the immune system at unprecedented scale and granularity. The map, paired with machine learning, looks at how the immune system will respond to drug targets, offering an affordable way to prevent expensive drug failures. The ultimate goal is to market immune treatments for diseases like cancer faster than ever before. In this wee…

1
Decoding Multi-Cloud Integration for Technology Leaders with SADA and Insight Part 1 | EP 174 20:40

7M ago20:40

20:40

Join Miles Ward, CTO of SADA, and his guest Juan Orlandini, CTO at Insight, on the latest episode of Cloud and Clear for a deep dive into the future of cloud computing. The conversation highlights how businesses navigate the complexities of adopting cloud technologies as they explore the journey from traditional to multi-cloud and hybrid environmen…

Подкасти, які варто послухати

Подкасти на тему Drug Discovery News

Подкасти, які варто послухати

Короткий довідник